Xvivo Perfusion AB logo

Xvivo Perfusion AB (0RKL)

Market Closed
5 Dec, 15:30
LSE LSE
kr
184. 97
+9.17
+5.22%
kr
12.08B Market Cap
384.18 P/E Ratio
0% Div Yield
1,132 Volume
1.4 Eps
kr 175.8
Previous Close
Day Range
183.05 187.5
Year Range
183.05 343.52
Want to track 0RKL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 49 days

Summary

0RKL closed Friday higher at kr184.97, an increase of 5.22% from Thursday's close, completing a monthly increase of 13.06% or kr21.37. Over the past 12 months, 0RKL stock lost -62.78%.
0RKL is not paying dividends to its shareholders.
The last earnings report, released on Oct 23, 2025, missed the consensus estimates by -1.92%. On average, the company has fell short of earnings expectations by -0.83%, based on the last three reports. The next scheduled earnings report is due on Jan 26, 2026.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XBER (EUR).

0RKL Chart

Similar

Sectra AB Class B Shares
kr 273.8
-0.73%

Xvivo Perfusion AB (0RKL) FAQ

What is the stock price today?

The current price is kr184.97.

On which exchange is it traded?

Xvivo Perfusion AB is listed on XBER.

What is its stock symbol?

The ticker symbol is 0RKL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 12.08B.

When is the next earnings date?

The next earnings report will release on Jan 26, 2026.

Has Xvivo Perfusion AB ever had a stock split?

No, there has never been a stock split.

Xvivo Perfusion AB Profile

Life Sciences Tools & Services Industry
Healthcare Sector
Mr. Christoffer Rosenblad CEO
LSE Exchange
- ISIN
SE Country
193 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Xvivo Perfusion AB (publ) stands as a pioneering medical technology company with its operations grounded in the development of innovative solutions for the preservation and perfusion of organs, tissues, and cells geared towards transplantation. Established in 1998, the company carves its niche in the global transplants market, serving a wide geographical footprint that spans across Sweden, the United States, North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. With its headquarters in Gothenburg, Sweden, Xvivo Perfusion AB harnesses its expertise to address critical needs within the transplantation space, thereby facilitating improved outcomes for patients worldwide.

Products and Services

  • XVIVO System (XPS)
  • An all-encompassing off-the-shelf cardiac bypass system, the XVIVO System encompasses a suite of components necessary to execute safe normothermic ex vivo lung perfusion (EVLP). This groundbreaking system offers a solution designed to preserve donor lungs in an optimal condition until transplantation.

  • XPS Disposable Lung Kit
  • Designed to meet the stringent requirement for sterility, this kit includes disposables and pre-packed products tailored for use with the XPS system, providing a streamlined approach to lung preservation during EVLP.

  • STEEN Solution
  • This uniquely formulated buffered extracellular solution is optimally concocted to perfuse isolated donor lungs during the EVLP process. STEEN Solution plays a pivotal role in maintaining the organ in a suitable condition for transplantation.

  • Perfadex Plus
  • An advanced extracellular, low potassium, dextran-based electrolyte preservation solution, Perfadex Plus is integral for the effective preservation of donor lungs, facilitating their optimal condition until the time of transplantation.

  • XVIVO Silicone Tubing Set
  • Essential for the rapid flushing of donor lungs during procurement, the XVIVO Silicone Tubing Set is designed to ensure that the organs are quickly and efficiently preserved at the point of donation.

  • XVIVO LS and XVIVO Disposable Lung Set
  • A device specifically created for use in EVLP, the XVIVO LS and Disposable Lung Set are critical in the process of lung preservation, ensuring organs remain in the best possible condition for transplantation.

  • XVIVO Organ Chamber
  • A sterile, disposable container intended for use as a temporary receptacle for isolated lungs in preparation for transplantation. The organ chamber is a key component in ensuring the safe and sterile handling of donor lungs.

  • XVIVO Lung Cannula Set
  • As a single-use, sterile disposable product, the XVIVO Lung Cannula Set is designed for the specific requirements of lung transplantation, ensuring a seamless connection between donor lungs and the recipient.

Contact Information

Address: MAessans gata 10
Phone: 46 3 17 88 21 50